|
|
||||||||
Vol. 53, Issue 1, 135-159, March 2001
Institute of Pharmacology, University of Messina, Messina, Italy
(S.C., A.P.C.); and Metaphore Pharmaceuticals, St. Louis, Missouri
(D.P.R., D.S.)
I. Introduction
A. Oxygen Radical
B. Nitrogen Species
II. DNA Damage
III. Poly(ADP-Ribose) Synthetase
IV. Relative Importance of Reactions of Glutathione with Nitric
Oxide, Oxyradicals, and Peroxynitrite in Endotoxic Shock and
Inflammation
V. Superoxide Dismutase
VI. Radical Generation
A. In Ischemia/Reperfusion
B. In Shock and Inflammation
VII. Pharmacological Intervention to Reduce Reactive Oxygen Species
Generation in Shock, Inflammation, and Ischemia/Reperfusion
A. Peroxynitrite Decomposition Catalysts as Anti-inflammatory
Agents
B. Catalytic Antioxidants
C. Metalloporphyrins
1. Effects of Metalloporphyrins in Inflammation.
2. Effect of Metalloporphyrins in Endotoxic and Hemorrhagic Shock.
3. Limitations of Metalloporphyrins.
D. New Rational Synthetic Enzymes: Manganese(II)-Based Superoxide
Dismutase Mimics
1. Characterization of Superoxide Dismutase Activity.
2. Catalyst/Drug Design.
3. Anti-Inflammatory Activity of Superoxide Dismutase Mimics.
4. Attenuation of Myocardial Ischemia/Reperfusion Injury by
Superoxide Dismutase Mimics.
VIII. Conclusions and Future Directions
References
A vast amount of circumstantial evidence implicates oxygen-derived free radicals (especially superoxide and hydroxyl radical) and high-energy oxidants (such as peroxynitrite) as mediators of inflammation, shock, and ischemia/reperfusion injury. The aim of this review is to describe recent developments in the field of oxidative stress research. The first part of the review focuses on the roles of reactive oxygen species (ROS) in shock, inflammation, and ischemia/reperfusion injury. The second part of the review deals with the novel findings using recently identified pharmacological tools (e.g., peroxynitrite decomposition catalysts and selective superoxide dismutase mimetics (SODm) in shock, ischemia/reperfusion, and inflammation. 1) The role of ROS consists of immunohistochemical and biochemical evidence that demonstrates the production of ROS in shock, inflammation, and ischemia/reperfusion injury. ROS can initiate a wide range of toxic oxidative reactions. These include initiation of lipid peroxidation, direct inhibition of mitochondrial respiratory chain enzymes, inactivation of glyceraldehyde-3-phosphate dehydrogenase, inhibition of membrane sodium/potassium ATPase activity, inactivation of membrane sodium channels, and other oxidative modifications of proteins. All these toxicities are likely to play a role in the pathophysiology of shock, inflammation, and ischemia/reperfusion. 2) Treatment with either peroxynitrite decomposition catalysts, which selectively inhibit peroxynitrite, or with SODm, which selectively mimic the catalytic activity of the human superoxide dismutase enzymes, have been shown to prevent in vivo the delayed vascular decompensation and the cellular energetic failure associated with shock, inflammation, and ischemia/reperfusion injury. ROS (e.g., superoxide, peroxynitrite, hydroxyl radical, and hydrogen peroxide) are all potential reactants capable of initiating DNA single-strand breakage, with subsequent activation of the nuclear enzyme poly(ADP-ribose) synthetase, leading to eventual severe energy depletion of the cells and necrotic-type cell death. Antioxidant treatment inhibits the activation of poly(ADP-ribose) synthetase and prevents the organ injury associated with shock, inflammation, and ischemia/reperfusion.
This article has been cited by other articles:
![]() |
J. Iwanami, M. Mogi, J.-M. Li, K. Tsukuda, L.-J. Min, A. Sakata, T. Fujita, M. Iwai, and M. Horiuchi Deletion of Angiotensin II Type 2 Receptor Attenuates Protective Effects of Bone Marrow Stromal Cell Treatment on Ischemia-Reperfusion Brain Injury in Mice * Supplemental Materials and Methods Stroke, September 1, 2008; 39(9): 2554 - 2559. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Genovese, E. Esposito, E. Mazzon, R. D. Paola, R. Meli, P. Bramanti, D. Piomelli, A. Calignano, and S. Cuzzocrea Effects of Palmitoylethanolamide on Signaling Pathways Implicated in the Development of Spinal Cord Injury J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 12 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nakao, T. Kurokawa, T. Nonami, G. Tumurkhuu, N. Koide, and T. Yokochi Hydrogen peroxide induces the production of tumor necrosis factor-{alpha} in RAW 264.7 macrophage cells via activation of p38 and stress-activated protein kinase Innate Immunity, June 1, 2008; 14(3): 190 - 196. [Abstract] [PDF] |
||||
![]() |
C. Angeloni, E. Leoncini, M. Malaguti, S. Angelini, P. Hrelia, and S. Hrelia Role of quercetin in modulating rat cardiomyocyte gene expression profile Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1233 - H1243. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakashima, T. Iwashita, T. Fujita, E. Sato, Y. Niwano, M. Kohno, S. Kuwahara, N. Harada, S. Takeshita, and T. Oda A Prodigiosin Analogue Inactivates NADPH Oxidase in Macrophage Cells by Inhibiting Assembly of p47phox and Rac J. Biochem., January 1, 2008; 143(1): 107 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Karlsen, L. Retterstol, P. Laake, I. Paur, S. Kjolsrud-Bohn, L. Sandvik, and R. Blomhoff Anthocyanins Inhibit Nuclear Factor-{kappa}B Activation in Monocytes and Reduce Plasma Concentrations of Pro-Inflammatory Mediators in Healthy Adults J. Nutr., August 1, 2007; 137(8): 1951 - 1954. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R Jacobs Jr, L. F. Andersen, and R. Blomhoff Whole-grain consumption is associated with a reduced risk of noncardiovascular, noncancer death attributed to inflammatory diseases in the Iowa Women's Health Study Am. J. Clinical Nutrition, June 1, 2007; 85(6): 1606 - 1614. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pacher, J. S. Beckman, and L. Liaudet Nitric Oxide and Peroxynitrite in Health and Disease Physiol Rev, January 1, 2007; 87(1): 315 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cuzzocrea, S. Bruscoli, C. Crisafulli, E. Mazzon, M. Agostini, C. Muia, E. Esposito, R. Di Virgilio, R. Meli, E. Vegeto, et al. Estrogen Receptor Antagonist Fulvestrant (ICI 182,780) Inhibits the Anti-Inflammatory Effect of Glucocorticoids Mol. Pharmacol., January 1, 2007; 71(1): 132 - 144. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Berger Antioxidant Micronutrients in Major Trauma and Burns: Evidence and Practice Nutr Clin Pract, October 1, 2006; 21(5): 438 - 449. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Cao, H. Zhu, L. Zhang, X. Zhao, J. L. Zweier, and Y. Li Antioxidants and Phase 2 Enzymes in Cardiomyocytes: Chemical Inducibility and Chemoprotection Against Oxidant and Simulated Ischemia-Reperfusion Injury Experimental Biology and Medicine, September 1, 2006; 231(8): 1353 - 1364. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ohashi, Y. Ito, T. Matsuno, S. Sato, K. Shimokata, and H. Kume Paradoxical Effects of Hydrogen Peroxide on Human Airway Anion Secretion J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 296 - 303. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Andersen, D. R Jacobs Jr, M. H Carlsen, and R. Blomhoff Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study Am. J. Clinical Nutrition, May 1, 2006; 83(5): 1039 - 1046. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Genovese, E. Mazzon, C. Crisafulli, R. Di Paola, C. Muia, P. Bramanti, and S. Cuzzocrea Immunomodulatory Effects of Etanercept in an Experimental Model of Spinal Cord Injury J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1006 - 1016. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zamora, Y. Vodovotz, B. Betten, C. Wong, B. Zuckerbraun, K. F. Gibson, and H. R. Ford Intestinal and hepatic expression of BNIP3 in necrotizing enterocolitis: regulation by nitric oxide and peroxynitrite Am J Physiol Gastrointest Liver Physiol, November 1, 2005; 289(5): G822 - G830. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Barnes New approaches to COPD Eur. Respir. Rev., September 1, 2005; 14(94): 2 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Mysore, T. A. Shinkel, J. Collins, E. J. Salvaris, N. Fisicaro, L. J. Murray-Segal, L. E.A. Johnson, D. A. Lepore, S. N. Walters, R. Stokes, et al. Overexpression of Glutathione Peroxidase With Two Isoforms of Superoxide Dismutase Protects Mouse Islets From Oxidative Injury and Improves Islet Graft Function Diabetes, July 1, 2005; 54(7): 2109 - 2116. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Genovese, E. Mazzon, R. D. Paola, C. Muia, M. D. Threadgill, A. P. Caputi, C. Thiemermann, and S. Cuzzocrea Inhibitors of Poly(ADP-Ribose) Polymerase Modulate Signal Transduction Pathways and the Development of Bleomycin-Induced Lung Injury J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 529 - 538. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cuzzocrea, R. Di Paola, E. Mazzon, U. Cortes, T. Genovese, C. Muia, W. Li, W. Xu, J.-H. Li, J. Zhang, et al. PARG activity mediates intestinal injury induced by splanchnic artery occlusion and reperfusion FASEB J, April 1, 2005; 19(6): 558 - 566. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Barnes, I. M. Adcock, and K. Ito Histone acetylation and deacetylation: importance in inflammatory lung diseases Eur. Respir. J., March 1, 2005; 25(3): 552 - 563. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Barnes Mediators of Chronic Obstructive Pulmonary Disease Pharmacol. Rev., December 1, 2004; 56(4): 515 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Cui, C. Parent, H. Macarthur, S. D. Ochs, E. Gerstenberg, S. Solomon, Y. Fitz, R. L. Danner, S. M. Banks, C. Natanson, et al. Severity of sepsis alters the effects of superoxide anion inhibition in a rat sepsis model J Appl Physiol, October 1, 2004; 97(4): 1349 - 1357. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Di Filippo, F. Rossi, E. Ongini, P. Del Soldato, M. Perretti, and M. D'Amico The Distinct Alterations Produced in Cardiovascular Functions by Prednisolone and Nitro-prednisolone (NCX-1015) in the Rat Highlight a Causal Role for Endothelin-1 J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 1133 - 1141. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sarkar, Y. Sreenivasan, G. T. Ramesh, and S. K. Manna {beta}-D-Glucoside Suppresses Tumor Necrosis Factor-induced Activation of Nuclear Transcription Factor {kappa}B but Potentiates Apoptosis J. Biol. Chem., August 6, 2004; 279(32): 33768 - 33781. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ceriello and E. Motz Is Oxidative Stress the Pathogenic Mechanism Underlying Insulin Resistance, Diabetes, and Cardiovascular Disease? The Common Soil Hypothesis Revisited Arterioscler. Thromb. Vasc. Biol., May 1, 2004; 24(5): 816 - 823. [Abstract] [Full Text] |
||||
![]() |
S. CUZZOCREA, E. MAZZON, L. DUGO, R. DI PAOLA, A. P. CAPUTI, and D. SALVEMINI Superoxide: a key player in hypertension FASEB J, January 1, 2004; 18(1): 94 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pleiner, F. Mittermayer, G. Schaller, C. Marsik, R. J. MacAllister, and M. Wolzt Inflammation-induced vasoconstrictorhyporeactivity is caused by oxidative stress J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1656 - 1662. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yildirim, M. Gumus, S. Dalga, Y. N. Sahin, and F. Akcay Dehydroepiandrosterone Improves Hepatic Antioxidant Systems after Renal Ischemia-Reperfusion Injury in Rabbits Ann. Clin. Lab. Sci., October 1, 2003; 33(4): 459 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Callera, R. M. Touyz, S. A. Teixeira, M. N. Muscara, M. H. C. Carvalho, Z. B. Fortes, D. Nigro, E. L. Schiffrin, and R. C. Tostes ETA Receptor Blockade Decreases Vascular Superoxide Generation in DOCA-Salt Hypertension Hypertension, October 1, 2003; 42(4): 811 - 817. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Prokai, K. Prokai-Tatrai, P. Perjesi, A. D. Zharikova, E. J. Perez, R. Liu, and J. W. Simpkins Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection PNAS, September 30, 2003; 100(20): 11741 - 11746. [Abstract] [Full Text] [PDF] |
||||
![]() |
P J Barnes Chronic obstructive pulmonary disease * 12: New treatments for COPD Thorax, September 1, 2003; 58(9): 803 - 808. [Full Text] [PDF] |
||||
![]() |
L. Ding-Zhou, C. Marchand-Verrecchia, B. Palmier, N. Croci, P.-E. Chabrier, M. Plotkine, and I. Margaill Neuroprotective Effects of (S)-N-[4-[4-[(3,4-Dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)carbonyl]-1-piperazinyl]phenyl]-2-thiophenecarboximid-amide (BN 80933), an Inhibitor of Neuronal Nitric-Oxide Synthase and an Antioxidant, in Model of Transient Focal Cerebral Ischemia in Mice J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 588 - 594. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pfeilschifter, W. Eberhardt, and A. Huwiler Nitric Oxide and Mechanisms of Redox Signaling J. Am. Soc. Nephrol., August 1, 2003; 14(90003): S237 - 240. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Koshkin, X. Wang, P. E. Scherer, C. B. Chan, and M. B. Wheeler Mitochondrial Functional State in Clonal Pancreatic {beta}-Cells Exposed to Free Fatty Acids J. Biol. Chem., May 23, 2003; 278(22): 19709 - 19715. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ceriello New Insights on Oxidative Stress and Diabetic Complications May Lead to a "Causal" Antioxidant Therapy Diabetes Care, May 1, 2003; 26(5): 1589 - 1596. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. L. Ting, B. Earley, and M. A. Crowe Effect of repeated ketoprofen administration during surgical castration of bulls on cortisol, immunological function, feed intake, growth, and behavior J Anim Sci, May 1, 2003; 81(5): 1253 - 1264. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Medved, M. J. Brown, A. R. Bjorksten, J. A. Leppik, S. Sostaric, and M. J. McKenna N-acetylcysteine infusion alters blood redox status but not time to fatigue during intense exercise in humans J Appl Physiol, April 1, 2003; 94(4): 1572 - 1582. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. V. Turko and F. Murad Protein Nitration in Cardiovascular Diseases Pharmacol. Rev., December 1, 2002; 54(4): 619 - 634. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Goodyear-Bruch and J. D. Pierce Oxidative Stress in Critically Ill Patients Am. J. Crit. Care., November 1, 2002; 11(6): 543 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kobayashi, K. Kondo, N. Uehara, S. Otokozawa, N. Tsuji, A. Yagihashi, and N. Watanabe Endogenous Reactive Oxygen Species Is an Important Mediator of Miconazole Antifungal Effect Antimicrob. Agents Chemother., October 1, 2002; 46(10): 3113 - 3117. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kohen and A. Nyska Invited Review: Oxidation of Biological Systems: Oxidative Stress Phenomena, Antioxidants, Redox Reactions, and Methods for Their Quantification Toxicol Pathol, October 1, 2002; 30(6): 620 - 650. [Abstract] [PDF] |
||||
![]() |
U. Raj and L. Shimoda Oxygen-dependent signaling in pulmonary vascular smooth muscle Am J Physiol Lung Cell Mol Physiol, October 1, 2002; 283(4): L671 - L677. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pleiner, F. Mittermayer, G. Schaller, R. J. MacAllister, and M. Wolzt High Doses of Vitamin C Reverse Escherichia coli Endotoxin-Induced Hyporeactivity to Acetylcholine in the Human Forearm Circulation, September 17, 2002; 106(12): 1460 - 1464. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Lysiak, Q. A. T. Nguyen, and T. T. Turner Peptide and Nonpeptide Reactive Oxygen Scavengers Provide Partial Rescue of the Testis After Torsion J Androl, May 1, 2002; 23(3): 400 - 409. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nishida, K. L. Schey, S. Takagahara, K. Kontani, T. Katada, Y. Urano, T. Nagano, T. Nagao, and H. Kurose Activation Mechanism of Gi and Go by Reactive Oxygen Species J. Biol. Chem., March 8, 2002; 277(11): 9036 - 9042. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Visioli Effects of vitamin E on the endothelium: equivocal? {alpha}-tocopherol and endothelial dysfunction Cardiovasc Res, August 1, 2001; 51(2): 198 - 201. [Full Text] [PDF] |
||||
![]() |
J.L. Mehta, H.J. Chen, and D.Y. Li Protection of Myocytes From Hypoxia-Reoxygenation Injury by Nitric Oxide Is Mediated by Modulation of Transforming Growth Factor-{beta}1 Circulation, May 7, 2002; 105(18): 2206 - 2211. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |